Amit Shah Insider Trades & Stock Holdings

CFO · Oncotelic Therapeutics, Inc. · Latest filing Jun 22, 2026

Amit Shah, CFO at Oncotelic Therapeutics, Inc. has 1 Form 4 trade on file since Jun 22, 2026. Open-market activity: 1 purchase ($1K) and 0 sales ($0), net +$1K. Latest filing: acquired 20K shares of $OTLC on Jun 22, 2026 at $0.05.

Trades on file

1

Open-market bought

$1K

Open-market sold

$0

Net open-market

+$1K

Latest filing

Jun 22, 2026

All insider trades by Amit Shah

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 22, 2026	$OTLC	Buy (Open-market buy)	20K	$0.05	$1K			-20.0%	-20.0%		CFO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Amit Shah traded

• $OTLC

Frequently asked questions

Has Amit Shah been buying or selling stock?

Amit Shah has 1 open-market purchase and 0 open-market sales on file, net +$1K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Amit Shah's latest insider trade?

acquired 20K shares of $OTLC on Jun 22, 2026 at $0.05.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.